Hubert L. Allen, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 6,115 shares at $39.03 ($242K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($242k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.79 | 4,572 | $182K | 75.1% |
| 2 | $39.03 | 1,543 | $60K | 24.9% |
| Total | $39.60 avg | 6,115 | $242K | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $202K | — | Filing → |
| ABT | SELL | 2023-03-02 | $215K | — | Filing → |
| ABT | SELL | 2022-03-02 | $343K | — | Filing → |